Cargando…

Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities

In this review, we discuss the molecular characteristics, development, evolution, and therapeutic perspectives for pediatric high-grade glioma (pHGG) arising in cerebral hemispheres. Recently, the understanding of biology of pHGG experienced a revolution with discoveries arising from genomic and epi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haase, Santiago, Nuñez, Fernando M., Gauss, Jessica C., Thompson, Sarah, Brumley, Emily, Lowenstein, Pedro, Castro, Maria G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766684/ https://www.ncbi.nlm.nih.gov/pubmed/33348922 http://dx.doi.org/10.3390/ijms21249654

Ejemplares similares

Genetically Engineered Mouse Model of Brainstem High-Grade Glioma
por: Nunez, Fernando M., et al.
Publicado: (2020)

H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models
por: Haase, Santiago, et al.
Publicado: (2022)

Impact of epigenetic reprogramming on antitumor immune responses in glioma
por: McClellan, Brandon L., et al.
Publicado: (2023)

Topographic correlates of driver mutations and endogenous gene expression in pediatric diffuse midline gliomas and hemispheric high-grade gliomas
por: Kazarian, Eve, et al.
Publicado: (2021)

Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic Implications
por: Comba, Andrea, et al.
Publicado: (2021)

Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma
por: Koschmann, Carl, et al.
Publicado: (2016)

H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Pediatric High-Grade Gliomas
por: Garcia-Fabiani, Maria B., et al.
Publicado: (2023)

Author Correction: Topographic correlates of driver mutations and endogenous gene expression in pediatric diffuse midline gliomas and hemispheric high-grade gliomas
por: Kazarian, Eve, et al.
Publicado: (2021)

LGG-46. MOLECULAR CHARACTERIZATION OF HEMISPHERIC LOW-GRADE GLIOMAS IN CHILDREN
por: Mišove, Adéla, et al.
Publicado: (2020)

Risk Assessment by Pre-surgical Tractography in Left Hemisphere Low-Grade Gliomas
por: Ius, Tamara, et al.
Publicado: (2021)

Pediatric Low-Grade Gliomas
por: Collins, Kelly L., et al.
Publicado: (2020)

The complex interactions between the cellular and non-cellular components of the brain tumor microenvironmental landscape and their therapeutic implications
por: Faisal, Syed M., et al.
Publicado: (2022)

MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression
por: Catanzaro, Giuseppina, et al.
Publicado: (2022)

Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment
por: Franson, Andrea, et al.
Publicado: (2022)

Immune-stimulatory (TK/Flt3L) gene therapy opens the door to a promising new treatment strategy against brainstem gliomas
por: Faisal, Syed M., et al.
Publicado: (2020)

Current Approaches for Glioma Gene Therapy and Virotherapy
por: Banerjee, Kaushik, et al.
Publicado: (2021)

Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1
por: Alghamri, Mahmoud S, et al.
Publicado: (2020)

Medical Treatment of Pediatric Low-Grade Glioma
por: Lim, Yeon Jung
Publicado: (2022)

Chromatin mutations in pediatric high grade gliomas
por: Voon, Hsiao P. J., et al.
Publicado: (2023)

Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma
por: Williams, Maria J., et al.
Publicado: (2017)

Alternative Lengthening of Telomeres in Pediatric High-Grade Glioma and Therapeutic Implications
por: Umaru, Banlanjo, et al.
Publicado: (2023)

Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era
por: Manoharan, Neevika, et al.
Publicado: (2022)

LGG-02. PEDIATRIC LOW-GRADE GLIOMA RISK STRATIFICATION IN THE MOLECULAR ERA
por: Hata, Jessica, et al.
Publicado: (2021)

Mutations in chromatin machinery and pediatric high-grade glioma
por: Lulla, Rishi R., et al.
Publicado: (2016)

Pediatric low-grade glioma in the era of molecular diagnostics
por: Ryall, Scott, et al.
Publicado: (2020)

Predictors of Seizure Freedom in Pediatric Low-Grade Gliomas
por: Budnick, Hailey C, et al.
Publicado: (2022)

Pakistan National Guidelines for Pediatric High-Grade Gliomas
por: Bashir, Farrah, et al.
Publicado: (2023)

Retrospective analysis of hemispheric structural network change as a function of location and size of glioma
por: D’Souza, Shawn, et al.
Publicado: (2020)

Targeting gliomas with STAT3-silencing nanoparticles
por: Kadiyala, Padma, et al.
Publicado: (2021)

Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas
por: Fontebasso, Adam M., et al.
Publicado: (2013)

Pediatric diffuse hemispheric glioma H3 G34-mutant with gains of the BRAF locus: An illustrative case
por: Marlow, Christine, et al.
Publicado: (2023)

Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities
por: Diaz-Miqueli, Arlhee, et al.
Publicado: (2013)

HGG-41. STRUCTURAL VARIANT DRIVERS IN PEDIATRIC HIGH-GRADE GLIOMA
por: Dubois, Frank, et al.
Publicado: (2020)

Trotabresib, an oral potent bromodomain and extraterminal inhibitor, in patients with high-grade gliomas: A phase I, “window-of-opportunity” study
por: Moreno, Victor, et al.
Publicado: (2022)

Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies
por: Garcia-Fabiani, Maria B., et al.
Publicado: (2021)

T-Cell Immunotherapy for Pediatric High-Grade Gliomas: New Insights to Overcoming Therapeutic Challenges
por: Haydar, Dalia, et al.
Publicado: (2021)

Awake Surgery With Visual Pathway Mapping in Low Grade Glioma Surgery
por: Sangrador-Deitos, Marcos V, et al.
Publicado: (2022)

HGG-25. TARGETED DRUGS SYNERGIZE WITH DOUBLE ALKYLATOR THERAPY IN H3.3 G34R/V PEDIATRIC HIGH-GRADE GLIOMA
por: Haase, Rebecca, et al.
Publicado: (2023)

A Multi-Institutional Experience in Pediatric High-Grade Glioma
por: Walston, Steve, et al.
Publicado: (2015)

Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas
por: Salloum, Ralph, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u4st6c308fgu965lonv7k50a9e